161 related articles for article (PubMed ID: 22543627)
41. Cancer incidence in Familial Mediterranean Fever: A retrospective analysis.
Baspinar SN; Kilic B; Azman FN; Guler Y; Gunay UB; Tanin MK; Can G; Ugurlu S
Semin Arthritis Rheum; 2023 Dec; 63():152284. PubMed ID: 37979399
[TBL] [Abstract][Full Text] [Related]
42. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia.
Sevoyan MK; Sarkisian TF; Beglaryan AA; Shahsuvaryan GR; Armenian HK
Med Princ Pract; 2009; 18(6):441-6. PubMed ID: 19797919
[TBL] [Abstract][Full Text] [Related]
43. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis.
Mimouni A; Magal N; Stoffman N; Shohat T; Minasian A; Krasnov M; Halpern GJ; Rotter JI; Fischel-Ghodsian N; Danon YL; Shohat M
Pediatrics; 2000 May; 105(5):E70. PubMed ID: 10799634
[TBL] [Abstract][Full Text] [Related]
44. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.
Ben-Zvi I; Danilesko I; Yahalom G; Kukuy O; Rahamimov R; Livneh A; Kivity S
Isr Med Assoc J; 2012 Apr; 14(4):221-4. PubMed ID: 22675837
[TBL] [Abstract][Full Text] [Related]
46. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
Peces R; Afonso S; Peces C; Nevado J; Selgas R
BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
[TBL] [Abstract][Full Text] [Related]
47. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey.
Tuglular S; Yalcinkaya F; Paydas S; Oner A; Utas C; Bozfakioglu S; Ataman R; Akpolat T; Ok E; Sen S; Düsünsel R; Evrenkaya R; Akoglu E
Nephrol Dial Transplant; 2002 Nov; 17(11):2003-5. PubMed ID: 12401861
[TBL] [Abstract][Full Text] [Related]
48. Cardiac disease in familial Mediterranean fever.
Erken E; Erken E
Rheumatol Int; 2018 Jan; 38(1):51-58. PubMed ID: 29051974
[TBL] [Abstract][Full Text] [Related]
49. The prevention of amyloidosis in familial Mediterranean fever with colchicine.
Cabili S; Zemer D; Pras M; Aviram A; Sohar E; Gafni J
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():709-11. PubMed ID: 3991564
[TBL] [Abstract][Full Text] [Related]
50. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
[TBL] [Abstract][Full Text] [Related]
51. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy.
Ehrenfeld M; Brzezinski A; Levy M; Eliakim M
Br J Obstet Gynaecol; 1987 Dec; 94(12):1186-91. PubMed ID: 3426990
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
[TBL] [Abstract][Full Text] [Related]
53. Different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis.
Akar S; Solmaz D; Kasifoglu T; Bilge SY; Sari I; Gumus ZZ; Tunca M
Rheumatology (Oxford); 2016 Feb; 55(2):343-6. PubMed ID: 26370398
[TBL] [Abstract][Full Text] [Related]
54. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients.
Yalçinkaya F; Tekin M; Cakar N; Akar E; Akar N; Tümer N
QJM; 2000 Oct; 93(10):681-4. PubMed ID: 11029479
[TBL] [Abstract][Full Text] [Related]
55. Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.
Sayarlioglu H; Erkoc R; Sayarlioglu M; Dogan E; Soyoral Y
Rheumatol Int; 2006 Dec; 27(2):197-9. PubMed ID: 16944160
[TBL] [Abstract][Full Text] [Related]
56. Familial Mediterranean fever in the colchicine era: the fate of one family.
Zemer D; Livneh A; Pras M; Sohar E
Am J Med Genet; 1993 Feb; 45(3):340-4. PubMed ID: 8434621
[TBL] [Abstract][Full Text] [Related]
57. Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey.
Altiparmak MR; Pamuk ON; Ataman R; Serdengeçti K
Nephron Clin Pract; 2004; 98(4):c119-23. PubMed ID: 15627789
[TBL] [Abstract][Full Text] [Related]
58. Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.
Sevillano ÁM; Hernandez E; Gonzalez E; Mateo I; Gutierrez E; Morales E; Praga M
Nefrologia; 2016; 36(1):63-6. PubMed ID: 26409501
[TBL] [Abstract][Full Text] [Related]
59. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever.
Yildiz A; Akkaya V; Kiliçaslan I; Türkmen A; Görçin B; Atilgan D; Sever MS
J Nephrol; 2001; 14(2):125-7. PubMed ID: 11411014
[TBL] [Abstract][Full Text] [Related]
60. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.
Zemer D; Pras M; Sohar E; Modan M; Cabili S; Gafni J
N Engl J Med; 1986 Apr; 314(16):1001-5. PubMed ID: 3515182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
